Vyvanse prepares to lead ADHD class
Shire has amassed a 560-person sales force to launch its new ADHD drug Vyvanse. The sales team began targeting specialist physicians treating ADHD including pediatricians, pediatric neurologists and psychiatrists early last month.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.